Overview
Jana Wobst practices practicing medicine in Munich, Germany.
Her clinical expertise encompasses Coronary Heart Disease, Multiple Myeloma, Leukemia, and Atherosclerosis.
She is actively involved in clinical research, co-authoring 17 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jana Wobst
Is Jana Wobst a top-rated expert for Coronary Heart Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Jana Wobst is classified as an Experienced expert for Coronary Heart Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jana Wobst participate in research or clinical trials?
Yes. Jana Wobst has published 17 articles and abstracts on conditions like Coronary Heart Disease. You can view a list of Jana Wobst's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AtherosclerosisMs. Wobst isExperienced. Learn about Atherosclerosis.
- Coronary Heart DiseaseMs. Wobst isExperienced. Learn about Coronary Heart Disease.
- LeukemiaMs. Wobst isExperienced. Learn about Leukemia.
- Multiple MyelomaMs. Wobst isExperienced. Learn about Multiple Myeloma.